Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study106

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study36

Views

Views
November 20255
December 20254
January 20263
February 20260
March 202611
April 20268
May 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
United Kingdom8
Brazil2
Finland2
Argentina2
Chile1
Colombia1
Germany1
Algeria1
Spain1
 

Top cities views

Views
San Jose2
Helsinki2
Amsterdam1
Ashburn1
Bogotá1
Caerphilly1
Chattanooga1
Durban1
Edinburgh1
Enfield1